Literature DB >> 11994709

Expression and function of histamine receptors in human monocyte-derived dendritic cells.

Marco Idzko1, Andrea la Sala, Davide Ferrari, Elisabeth Panther, Yared Herouy, Stefan Dichmann, Maja Mockenhaupt, Francesco Di Virgilio, Giampiero Girolomoni, Johannes Norgauer.   

Abstract

BACKGROUND: Histamine is a well-known mediator eliciting different responses in immune and nonimmune cells, but its role in modulating dendritic cell (DC) functions has been marginally investigated.
OBJECTIVE: The purpose of this investigation was to analyze whether human monocyte-derived DCs express functional histamine receptors according to their maturation stage.
METHODS: DCs were derived from monocytes and used as immature or LPS-differentiated cells. DCs were tested for histamine receptor expression, chemotaxis, cytokine release, and the capacity to induce T-cell differentiation in response to specific histamine receptor agonists.
RESULTS: Immature and mature DCs expressed the mRNA for H1, H2, and H3 histamine receptors. Histamine induced intracellular Ca2+ transients, actin polymerization, and chemotaxis in immature DCs. Maturation of DCs resulted in the loss of these responses. In maturing DCs, however, histamine dose-dependently enhanced intracellular cAMP levels and stimulated IL-10 secretion while inhibiting production of IL-12. As a consequence, histamine might contribute to the impairment of generation of allogeneic type 1 responses via maturing DCs. Specific histamine receptor agonists or antagonists revealed that Ca2+ transients, actin polymerization, and chemotaxis of immature DCs were due to stimulation of H1 and H3 subtypes. Modulation of IL-12 and IL-10 secretion by histamine involved the H2 and H3 receptors exclusively.
CONCLUSIONS: Our study suggests that histamine has important biological effects on DC activities, opening the possibility that histamine released during inflammatory or immune responses could regulate DC functions and ultimately favor type 2 lymphocyte-dominated immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994709     DOI: 10.1067/mai.2002.124044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  23 in total

1.  Molecular recognition of organic ammonium ions in solution using synthetic receptors.

Authors:  Andreas Späth; Burkhard König
Journal:  Beilstein J Org Chem       Date:  2010-04-06       Impact factor: 2.883

2.  Histamine modulates γδ-T lymphocyte migration and cytotoxicity, via Gi and Gs protein-coupled signalling pathways.

Authors:  K Truta-Feles; M Lagadari; K Lehmann; L Berod; S Cubillos; S Piehler; Y Herouy; D Barz; T Kamradt; Aa Maghazachi; J Norgauer
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 3.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 4.  Functional diversity and plasticity of human dendritic cell subsets.

Authors:  Tomoki Ito; Yong-Jun Liu; Norimitsu Kadowaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

5.  Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function.

Authors:  M Wang; J Han; J Domenico; Y S Shin; Y Jia; E W Gelfand
Journal:  Allergy       Date:  2016-08-03       Impact factor: 13.146

6.  Modulation of tissue inflammatory response by histamine receptors in scorpion envenomation pathogenesis: involvement of H4 receptor.

Authors:  Amal Lamraoui; Sonia Adi-Bessalem; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 7.  Mast cells as regulators of adaptive immunity to tumours.

Authors:  A Wasiuk; V C de Vries; K Hartmann; A Roers; R J Noelle
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

Review 8.  Molecular and cellular analysis of human histamine receptor subtypes.

Authors:  Roland Seifert; Andrea Strasser; Erich H Schneider; Detlef Neumann; Stefan Dove; Armin Buschauer
Journal:  Trends Pharmacol Sci       Date:  2012-12-17       Impact factor: 14.819

Review 9.  How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.

Authors:  Anthony T Reder; Xuan Feng
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

10.  5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo.

Authors:  Tobias Müller; Thorsten Dürk; Britta Blumenthal; Melanie Grimm; Sanja Cicko; Elisabeth Panther; Stephan Sorichter; Yared Herouy; Francesco Di Virgilio; Davide Ferrari; Johannes Norgauer; Marco Idzko
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.